An algebra of dimerization and its implications for G-protein coupled receptor signaling.

Many species of receptors form dimers, but how can we use this information to make predictions about signal transduction? This problem is particularly difficult when receptors dimerize with many different species, leading to a combinatoric increase in the possible number of dimer pairs. As an example system, we focus on receptors in the G-protein coupled receptor (GPCR) family. GPCRs have been shown to reversibly form dimers, but this dimerization does not directly affect signal transduction. Here we present a new theoretical framework called a dimerization algebra. This algebra provides a systematic and rational way to represent, manipulate, and in some cases simplify large and often complicated networks of dimerization interactions. To compliment this algebra, Monte Carlo simulations are used to predict dimerization's effect on receptor organization on the membrane, signal transduction, and internalization. These simulation results are directly comparable to various experimental measures such as fluorescence resonance energy transfer (FRET), and as such provide a link between the dimerization algebra and experimental data. As an example, we show how the algebra and computational results can be used to predict the effects of dimerization on the dopamine D2 and somatastatin SSTR1 receptors. When these predictions were compared to experimental findings from the literature, good agreement was found, demonstrating the utility of our approach. Applications of this work to the development of a novel class of dimerization-modulating drugs are also discussed.

[1]  A. Cornea,et al.  Gonadotropin-releasing Hormone Receptor Microaggregation , 2001, The Journal of Biological Chemistry.

[2]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[3]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[4]  P. Strange,et al.  Dopamine D2 Receptor Dimer Formation , 2001, The Journal of Biological Chemistry.

[5]  L. Devi,et al.  Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. von Zastrow,et al.  Heterologous Inhibition of G Protein-coupled Receptor Endocytosis Mediated by Receptor-specific Trafficking of β-Arrestins* , 2001, The Journal of Biological Chemistry.

[7]  Lei Shi,et al.  The Fourth Transmembrane Segment Forms the Interface of the Dopamine D2 Receptor Homodimer* , 2003, The Journal of Biological Chemistry.

[8]  R. Neubig,et al.  Timing is everything the role of kinetics in G protein activation. , 2000, Life sciences.

[9]  R. Neubig,et al.  Multisite interactions of receptors and G proteins: enhanced potency of dimeric receptor peptides in modifying G protein function. , 1994, Molecular Pharmacology.

[10]  C. Reynolds,et al.  G-protein Coupled Receptor Dimerization , 2003 .

[11]  Peter J Woolf,et al.  Self organization of membrane proteins via dimerization. , 2003, Biophysical chemistry.

[12]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[13]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[14]  J. Hörber,et al.  Sphingolipid–Cholesterol Rafts Diffuse as Small Entities in the Plasma Membrane of Mammalian Cells , 2000, The Journal of cell biology.

[15]  L. Daeffler,et al.  Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential , 2000, Fundamental & clinical pharmacology.

[16]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[17]  U. Kumar,et al.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. , 2000, Science.

[18]  Peter J Woolf,et al.  A Spatial Focusing Model for G Protein Signals , 2003, The Journal of Biological Chemistry.

[19]  S. Senogles The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins. , 1994, The Journal of biological chemistry.

[20]  J. Wess,et al.  Identification and Molecular Characterization of m3 Muscarinic Receptor Dimers* , 1999, The Journal of Biological Chemistry.

[21]  P. Woolf COMPUTATIONAL ANALYSIS OF G-PROTEIN COUPLED RECEPTOR SCREENING, DIMERIZATION, AND DESENSITIZATION , 2002 .

[22]  J. Linderman,et al.  A Monte Carlo study of the dynamics of G-protein activation. , 1994, Biophysical journal.

[23]  Y. Yarden,et al.  The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions , 1997, FEBS letters.

[24]  H. Lother,et al.  Involvement of the Amino Terminus of the B2 Receptor in Agonist-induced Receptor Dimerization* , 1999, The Journal of Biological Chemistry.

[25]  Michel Bouvier,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000 .

[26]  T. Issad,et al.  A homogenous assay to monitor the activity of the insulin receptor using Bioluminescence Resonance Energy Transfer. , 2002, Biochemical pharmacology.

[27]  J. Venter,et al.  Molecular size of the human platelet alpha 2-adrenergic receptor as determined by radiation inactivation. , 1983, Biochemical and biophysical research communications.

[28]  P. Negulescu,et al.  High-throughput screening strategies for cardiac ion channels. , 2001, Trends in cardiovascular medicine.

[29]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[30]  U. Kumar,et al.  Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers* , 2000, The Journal of Biological Chemistry.

[31]  M. Saxton,et al.  The spectrin network as a barrier to lateral diffusion in erythrocytes. A percolation analysis. , 1989, Biophysical journal.

[32]  Paul D. Scott,et al.  Dimerization of G-protein-coupled receptors. , 2001 .

[33]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. von Zastrow,et al.  Type-specific Sorting of G Protein-coupled Receptors after Endocytosis* , 2000, The Journal of Biological Chemistry.

[35]  G. Demontis,et al.  G protein-linked receptors: pharmacological evidence for the formation of heterodimers. , 1999, The Journal of pharmacology and experimental therapeutics.